Lipocine announces annual shareholder meeting

• Lipocine schedules annual shareholder meeting in Salt Lake City on June 3, 2026.
• Shareholders to vote on election of four directors.
• Ballot includes advisory say-on-pay vote covering named executive officer compensation for fiscal 2025.
• Investors to consider amendment to 2014 Stock and Incentive Plan, lifting annual individual award limit to 100,000 shares from 25,000.
• Plan amendment also raises authorized shares issuable under the plan to 1,000,000 from 600,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lipocine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-018335), on April 21, 2026, and is solely responsible for the information contained therein.